{
    "Trade/Device Name(s)": [
        "ACE BUN/Urea Reagent",
        "ACE Creatinine Reagent",
        "ACE Uric Acid Reagent",
        "ACE CK Reagent",
        "ACE Axcel Clinical Chemistry Analyzer",
        "ACE Axcel Clinical Chemistry System"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K113389",
    "Predicate Device Reference 510(k) Number(s)": [
        "K930104"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CDN",
        "CGX",
        "KNK",
        "CGS"
    ],
    "Summary Letter Date": "July 31, 2012",
    "Summary Letter Received Date": "August 1, 2012",
    "Submission Date": "November 1, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1770",
        "21 CFR 862.1225",
        "21 CFR 862.1775",
        "21 CFR 862.1215",
        "21 CFR 862.2610"
    ],
    "Regulation Name(s)": [
        "Urea nitrogen test system",
        "Creatinine test system",
        "Uric acid test system",
        "Creatine phosphokinase or isoenzymes test system",
        "Photometric, Discrete Clinical Chemistry Analyzer"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Blood Urea Nitrogen (BUN)",
        "Creatinine",
        "Uric Acid",
        "Creatine Kinase"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACE Axcel Clinical Chemistry System",
        "ACE Axcel Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic (urease) photometric measurement for BUN/Urea",
        "Alkaline picrate colorimetry for creatinine",
        "Uricase colorimetric method for uric acid",
        "NAD reduction/NADH oxidation for creatine kinase"
    ],
    "Methodologies": [
        "Photometric analysis",
        "Colorimetric assay",
        "Enzymatic assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ACE BUN, Creatinine, Uric Acid, and CK reagents and ACE Axcel Clinical Chemistry Analyzer for quantitative measurement of BUN, creatinine, uric acid, and creatine kinase in serum.",
    "Indications for Use Summary": "Intended for quantitative determination of blood urea nitrogen, creatinine, uric acid, and creatine kinase activity in serum using the ACE Axcel Clinical Chemistry System, aiding in diagnosis and treatment of renal, metabolic, cardiac, and muscular diseases; for in vitro diagnostic use in clinical or physician office laboratories.",
    "fda_folder": "Clinical Chemistry"
}